De Célix, CR, Ricart, E, Martín-Arranz, MD, de Francisco, R, Barrio, J, Mesonero, F, Gomollón, F, de Castro, L, Ramos, L, García-López, S, Arias, L, Mañosa, M, Iglesias, E, Calvet, X, Pascual, I, Casanova, MJ, Pérez-Calle, JL, Giordano, A, Sierra, M, Vera, I, Navarro-Llavat, M, Lorente, R, Piqueras, M, Rivero, M, Guardiola, J, Esteve, M, Coronel, AF, Rodríguez-Lago, I, Ponferrada, A, Ber, Y, Tardillo, C, Márquez, L, Carpio, D, Taxonera, C, Bermejo, F, Busquets, D, Camps, B, Domènech, E, Chaparro, M, Gisbert, JP. Frequency and effectiveness of dose de-escalation of biologic therapy in Inflammatory Bowel Disease: The RAINBOW-IBD study of ENEIDA. Journal of Crohns & Colitis. 2024; 18DOI:. PMID:. IF:8.700(Q1/1D).

Capón, JG, Iborra, M, Padró, A, de la Peña, L, Serra, K, Martin-Arranz, MD, Domènech, E, Fernandez, A, Mesonero, F, Gonzalez-Muñoza, C, Ferreiro-Iglesias, R, Navarro, P, Martín-Cardona, A, Sicilia, B, Sierra-Ausin, M, Calvet, X, Marquez, L, de Francisco, R, Cañete, F, Gutierrez, A, García-López, S, Rivero, M, Hinojosa, J, Iglesias-Flores, E, Nos, P, Riestra, S, Bosca-Watts, M, Zabana, Y, Castro, B, Barreiro, M, Garcia-Planella, E, Ricart, E, De Francisco, R, Suris, G, Ruiz-Cerulla, A, Rodriguez-Alonso, L, Orobitg, J, Rodríguez-Moranta, F. Effect of the HLA-DQA1*05 allele on the efficacy of ustekinumab in patients with Crohn's Disease. Multicenter study based on the ENEIDA registry of GETECCU.. Journal of Crohns & Colitis. 2024; 18DOI:. PMID:. IF:8.700(Q1/1D).

Torrico M.C., Ballart C., Fernández-Arévalo A., Solano M., Rojas E., Abras A., Gonzales F., Mamani Y., Arnau A., Lozano D., Gascón J., Picado A., Torrico F., Muñoz C., Gállego M.. The need for culture in tegumentary leishmaniasis diagnosis in Bolivia: A comparative evaluation of four parasitological techniques using two sampling methods. ACTA TROPICA. 2024; 250DOI:10.1016/j.actatropica.2023.107092. PMID:38065375. IF:2.500(Q1/1D).

Ortiz, MA, Diaz-Torne, C, De Agustin, JJ, Estrada, P, Reina, D, Hernandez, MV, Sang, HY, Zamora, C, Canto, E, Corominas, H, Vidal, S. Altered CD39 and CD73 Expression in Rheumatoid Arthritis: Implications for Disease Activity and Treatment Response. Biomolecules. 2024; 14(1)DOI:10.3390/biom14010001. PMID:38275742. IF:4.800(Q1/3D).